$CRMZ
CREDITRISKMONITOR COM INC

2024 Q1 Form 10-K Financial Statement

#000114036124014541 Filed on March 21, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $4.809M $4.866M $18.93M
YoY Change 4.75% 4.79% 5.3%
Cost Of Revenue $2.198M $2.027M $7.833M
YoY Change 14.45% 8.58% 12.15%
Gross Profit $2.611M $2.839M $11.10M
YoY Change -2.23% 2.24% 0.95%
Gross Profit Margin 54.3% 58.34% 58.63%
Selling, General & Admin $2.554M $2.172M $9.223M
YoY Change 8.25% -0.19% 2.02%
% of Gross Profit 97.8% 76.52% 83.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $93.17K $93.77K $383.8K
YoY Change -4.46% 16.22% 0.37%
% of Gross Profit 3.57% 3.3% 3.46%
Operating Expenses $4.845M $2.268M $17.44M
YoY Change 10.68% 0.47% 85.08%
Operating Profit -$35.84K $571.2K $1.492M
YoY Change -116.76% 9.93% -5.05%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $201.8K $193.7K $715.3K
YoY Change 43.11% 69.33% 295.73%
Pretax Income $165.9K $764.9K $2.207M
YoY Change -53.23% 20.65% 25.98%
Income Tax $38.51K $175.1K $512.4K
% Of Pretax Income 23.21% 22.89% 23.21%
Net Earnings $127.4K $589.8K $1.695M
YoY Change -53.72% 15.53% 24.61%
Net Earnings / Revenue 2.65% 12.12% 8.95%
Basic Earnings Per Share $0.01 $0.16
Diluted Earnings Per Share $0.01 $0.05 $0.16
COMMON SHARES
Basic Shares Outstanding 10.72M 10.72M 10.72M
Diluted Shares Outstanding 10.77M 10.80M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.96M $14.50M
YoY Change 9.18% 4.35%
Cash & Equivalents $11.42M $11.00M
Short-Term Investments $3.539M $3.495M
Other Short-Term Assets $806.7K $788.7K
YoY Change 22.88% 20.16%
Inventory
Prepaid Expenses
Receivables $3.793M $3.941M
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.55M $19.23M
YoY Change 10.06% 6.53%
LONG-TERM ASSETS
Property, Plant & Equipment $661.7K $557.6K
YoY Change 11.47% -75.74%
Goodwill $1.954M $1.954M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $700.0K $700.0K
YoY Change
Other Assets $18.11K $18.11K
YoY Change 0.0% -88.92%
Total Long-Term Assets $4.894M $4.843M
YoY Change 12.97% 9.66%
TOTAL ASSETS
Total Short-Term Assets $19.55M $19.23M
Total Long-Term Assets $4.894M $4.843M
Total Assets $24.45M $24.07M
YoY Change 10.63% 7.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $238.2K $142.0K
YoY Change 95.08% -42.26%
Accrued Expenses $1.315M $2.105M
YoY Change 10.14% -12.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.88M $12.73M
YoY Change 7.27% 0.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.695M $1.623M
YoY Change -10.02% -15.87%
Total Long-Term Liabilities $1.695M $1.623M
YoY Change -10.02% -15.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.88M $12.73M
Total Long-Term Liabilities $1.695M $1.623M
Total Liabilities $14.93M $14.70M
YoY Change 4.94% -1.3%
SHAREHOLDERS EQUITY
Retained Earnings -$20.62M -$20.75M
YoY Change -6.98% -7.55%
Common Stock $107.2K $107.2K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.520M $9.368M
YoY Change
Total Liabilities & Shareholders Equity $24.45M $24.07M
YoY Change 10.63% 7.14%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $127.4K $589.8K $1.695M
YoY Change -53.72% 15.53% 24.61%
Depreciation, Depletion And Amortization $93.17K $93.77K $383.8K
YoY Change -4.46% 16.22% 0.37%
Cash From Operating Activities $608.8K $79.31K $1.449M
YoY Change -447.72% -75.46% -16.92%
INVESTING ACTIVITIES
Capital Expenditures $197.3K $153.9K $303.9K
YoY Change 267.61% 152.13% 17.81%
Acquisitions
YoY Change
Other Investing Activities -$330.00 -$7.100K -$7.100K
YoY Change -105.49% -99.82% -99.82%
Cash From Investing Activities -$197.6K -$161.0K -$311.0K
YoY Change 314.62% -96.04% -92.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 608.8K 79.31K 1.449M
Cash From Investing Activities -197.6K -161.0K -311.0K
Cash From Financing Activities
Net Change In Cash 411.2K -81.69K 1.138M
YoY Change -284.61% -97.82% -145.26%
FREE CASH FLOW
Cash From Operating Activities $608.8K $79.31K $1.449M
Capital Expenditures $197.3K $153.9K $303.9K
Free Cash Flow $411.5K -$74.59K $1.145M
YoY Change -279.91% -128.46% -22.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000315958
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Auditor Firm
AuditorFirmId
596
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
1-8601
CY2023 dei Entity Registrant Name
EntityRegistrantName
CreditRiskMonitor.com, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-2972588
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
704 Executive Boulevard
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Valley Cottage
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10989
CY2023 dei City Area Code
CityAreaCode
845
CY2023 dei Local Phone Number
LocalPhoneNumber
230-3000
CY2023 dei Security12g Title
Security12gTitle
Common Stock $.01 Par Value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
11775362
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10722401
CY2023 dei Auditor Name
AuditorName
CohnReznick LLP
CY2023 dei Auditor Location
AuditorLocation
New York, New York
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11004937
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9866628
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
3494958
CY2022Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
4028565
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3941182
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3500259
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
788722
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
656379
CY2023Q4 us-gaap Assets Current
AssetsCurrent
19229799
CY2022Q4 us-gaap Assets Current
AssetsCurrent
18051831
CY2023Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
700000
CY2022Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
0
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
557634
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
481804
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1612512
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1816505
CY2023Q4 us-gaap Goodwill
Goodwill
1954460
CY2022Q4 us-gaap Goodwill
Goodwill
1954460
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18110
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163470
CY2023Q4 us-gaap Assets
Assets
24072515
CY2022Q4 us-gaap Assets
Assets
22468070
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10272352
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9980092
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
141956
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
245854
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
211488
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
193953
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2105019
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2216376
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12730815
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12636275
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
350605
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
332566
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
68523
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
163320
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1554686
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1766174
CY2023Q4 us-gaap Liabilities
Liabilities
14704629
CY2022Q4 us-gaap Liabilities
Liabilities
14898335
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
107224
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
107224
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30007773
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29904675
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20747111
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22442164
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9367886
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7569735
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24072515
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22468070
CY2023 us-gaap Revenues
Revenues
18931931
CY2022 us-gaap Revenues
Revenues
17979317
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7833037
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6984729
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9223031
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9040767
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
383767
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
382342
CY2023 us-gaap Operating Expenses
OperatingExpenses
17439835
CY2022 us-gaap Operating Expenses
OperatingExpenses
16407838
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
1492096
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
1571479
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
715330
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
180762
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2207426
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1752241
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
512373
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
392003
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1695053
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1360238
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6129064
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1360238
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
80433
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7569735
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1695053
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
103098
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9367886
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1695053
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1360238
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-164531
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-27131
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18039
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-75239
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
383767
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
382342
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10040
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
18166
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
103098
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
80433
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
440923
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
697023
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
137444
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
75230
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
76757
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
197462
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
496063
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-103897
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-112453
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-111357
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
471086
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1449307
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1744495
CY2023 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
5010000
CY2022 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0
CY2023 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
5017103
CY2022 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
4001434
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
303895
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
257954
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-310998
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4259388
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1138309
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2514893
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9866628
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12381521
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11004937
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9866628
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
468000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
395000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align: justify; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Concentrations of Credit Risk</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk principally consist of cash, cash equivalents, available-for-sale securities and accounts receivable. The Company maintains its cash and cash equivalents in bank deposits and other accounts, the balances of which, at times, may exceed federally insured limits. Exposure to credit risk is reduced by placing such deposits in high credit quality financial institutions.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company closely monitors the extension of credit to its subscribers. The Company’s accounts receivable balance is net of an allowance for doubtful accounts. The Company does not require collateral or other security to support credit sales but provides an allowance for doubtful accounts of $30,000 as of December 31, 2023 and 2022, based on historical experience and specifically identified risks. Accounts receivable are charged off against the allowance for doubtful accounts when management determines that recovery is unlikely and the Company ceases collection efforts. The Company does not believe that significant credit risk existed at December 31, 2023 nor 2022.</div>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2023Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
11828
CY2023Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
3494958
CY2023Q4 crmz Held To Maturity Securities Debt Maturities After One Through Two Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughTwoYearsNetCarryingAmount
700000
CY2023Q4 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
4194958
CY2023 crmz Other Than Temporary Impairment Loss Debt Securities Held To Maturity Before Tax
OtherThanTemporaryImpairmentLossDebtSecuritiesHeldToMaturityBeforeTax
0
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
478379
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
449194
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
15956
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
18048
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
16754
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-70613
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1284
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4626
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
512373
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
392003
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
476239
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
367452
CY2023 crmz Income Tax Reconciliation Permanent Differrences
IncomeTaxReconciliationPermanentDifferrences
24056
CY2022 crmz Income Tax Reconciliation Permanent Differrences
IncomeTaxReconciliationPermanentDifferrences
15685
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
17537
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
13137
CY2023 crmz Effective Income Tax Rate Reconciliation True Up Current Taxes
EffectiveIncomeTaxRateReconciliationTrueUpCurrentTaxes
-123523
CY2022 crmz Effective Income Tax Rate Reconciliation True Up Current Taxes
EffectiveIncomeTaxRateReconciliationTrueUpCurrentTaxes
3709
CY2023 crmz Effective Income Tax Rate Reconciliation True Up Deferred Taxes
EffectiveIncomeTaxRateReconciliationTrueUpDeferredTaxes
117464
CY2022 crmz Effective Income Tax Rate Reconciliation True Up Deferred Taxes
EffectiveIncomeTaxRateReconciliationTrueUpDeferredTaxes
-6158
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
600
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-1822
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
512373
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
392003
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
22830
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
21654
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
109955
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
91161
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
6557
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
6546
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1007
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1222
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
28224
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
25982
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
929
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
46228
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
169502
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
192793
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
427204
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
426433
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
92903
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
98926
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
520107
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
525359
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
350605
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
332566
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 crmz Number Of Stock Option Plans
NumberOfStockOptionPlans
2
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
580950
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
103098
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
80433
CY2022 crmz Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
139782
CY2023 crmz Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
236600
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0191
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7456
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7109
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y4M24D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M25D
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
714050
CY2023 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y4M20D
CY2023Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
2.14
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
211660
CY2023Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.23
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
516193
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P5Y4M6D
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3576896
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3117299
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3019262
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2635495
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
557634
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
481804
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
287356
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
295975
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
304855
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
314000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
323420
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
530803
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2056409
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
290235
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1766174
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
211488
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1554686
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1766174
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
289024
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
289024
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0454
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1695053
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1360238
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
315862
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
237000
CY2023 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
241141
CY2022 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
198511
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10797122
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10760890
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
155700
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Name
AuditorName
CohnReznick LLP
CY2023 dei Auditor Location
AuditorLocation
New York, New York

Files In Submission

Name View Source Status
0001140361-24-014541-index-headers.html Edgar Link pending
0001140361-24-014541-index.html Edgar Link pending
0001140361-24-014541.txt Edgar Link pending
0001140361-24-014541-xbrl.zip Edgar Link pending
crmz-20231231.xsd Edgar Link pending
ef20015334_10k.htm Edgar Link pending
ef20015334_ex23.htm Edgar Link pending
ef20015334_ex31-1.htm Edgar Link pending
ef20015334_ex31-2.htm Edgar Link pending
ef20015334_ex32-1.htm Edgar Link pending
ef20015334_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
crmz-20231231_def.xml Edgar Link unprocessable
crmz-20231231_lab.xml Edgar Link unprocessable
crmz-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ef20015334_10k_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crmz-20231231_cal.xml Edgar Link unprocessable